Delaware

Delaware

16,497
Registered Patient Population
1.69%
of Total Population Represented by Patients
6
Total Medical Retail Locations Currently in Operation
2,750 : 1
Patients : Retail

Under the law registered patients and designated caregivers may possess up to six ounces of usable cannabis, but no personal cultivation is allowed. Patients and caregivers may possess up to 2.5 ounces of cannabis. Qualifying patients and caregivers are protected from discrimination in employment, education, housing, parental rights, and medical care, including organ transplants. Patients report feeling irritated about inconsistent product availability at dispensaries. There is no reciprocity available for patients visiting Delaware.

Patient Rights and Civil Protections 90/100   
Arrest Protection 25/25
Affirmative Defense 20/20
Parental Rights Protections 20/20
Employment Protections 20/20
DUI Protections 0/10
Explicit Privacy Standards 5/5
Access to Medicine 45/100   
Authorizes Retail Access 10/10
Alternative Accessibility Methods 20/20
- Authorizes Delivery 10/10
- Authorizes Curbside Pickup 10/10
Personal Cultivation 0/15
Collective Gardening 0/5
Sufficient Number of Licenced Retailers 15/30
Reciprocity 0/20
Program Functionality 95/100   
Legal Protections Within Reasonable Time Frame 15/20
Reasonable Possession Limits 10/10
Reasonable Purchase Limits 10/10
Telemedicine for Physician Certifications 15/15
Patient and Physician Representation in Program Decision Making 20/20
Reasonable Caregiver Standards 5/5
- Background Checks 2/2
- Number of Caregivers 3/3
Reasonable Physician Standards 5/5
Access to Administration Methods 10/10
- Allows Dried Flower 5/5
- Allows Edibles, Concentrates, and Other Forms 5/5
Provides Access to Minors on School Grounds 5/5
Affordability 50/100   
Sales Tax Break for Patients and Caregivers 20/20
Covered by State Insurance or Health Aid 0/20
Reasonable Registration Fees 20/20
Financial Hardship Waivers or Discounts 10/20
Donation Program 0/10
Allows Multi-Year Registrations 0/10
Health and Social Equity 76/100   
State Program Protections 25/25
Housing Protections 15/25
Access for Minors 10/10
Access in Underserved Areas 5/10
List of Qualifying Conditions is Exhaustive or All Inclusive 10/10
Allows Patients to Medicate Where they Choose 5/10
Organ Transplants 5/5
Ownership or Employment Restrictions 1/5
Consumer Protection and Product Safety 116/200   
Total 9/50
Quality Management Systems 0/10
Staff Training 0/10
Standard Operating Procedures 0/8
- Facility and Equipment Sanitation 0/1
- Workplace Safety 0/1
- Storage 0/1
- Batch and Lot Tracking 0/1
- Security 0/1
- Waste Disposal 0/1
- Water Management 0/1
- Records Management 0/1
Pesticide Usage Limitations 2/2
Environmental Impact Regulations 0/2
Required Testing 5/8
- Cannabinoids 1/1
- Terpenes 1/1
- Microbials 1/1
- Aflatoxins 1/1
- Pesticides 0/1
- Heavy Metals 0/1
- Foreign Matter 1/1
- Moisture Content/ Water Activity 0/1
Packaging and Labeling 2/3
- Cannabinoids 1/1
- Terpenes 0/1
- Pesticides 1/1
Complaints, Adverse Event Reporting, and Recall Protocol 0/7
Total 28/50
Quality Management Systems 10/10
Staff Training 5/10
Standard Operating Procedures 0/7
- Facility and Equipment Sanitation 0/1
- Workplace Safety 0/1
- Storage 0/1
- Batch and Lot Tracking 0/1
- Security 0/1
- Waste Disposal 0/1
- Records Management 0/1
Environmental Impact Regulations 0/3
Required Testing 6/10
- Cannabinoids 1/1
- Terpenes 1/1
- Microbials 1/1
- Aflatoxins 1/1
- Pesticides 0/1
- Heavy Metals 0/1
- Residual Solvents 1/1
- Homogeneity 0/1
- Foreign Matter 1/1
- Water Activity 0/1
Packaging and Labeling 4/5
- Cannabinoids 1/1
- Terpenes 0/1
- Ingredients 1/1
- Allergens 1/1
- Nutritional Content 1/1
Complaints, Adverse Event Reporting and Recall Protocol 3/5
Total 29/50
Staff Training 20/20
Standard Operating Procedures 4/7
- Facility Sanitation 0/1
- Workplace Safety 1/1
- Storage 0/1
- Batch and Lot Tracking 1/1
- Security 1/1
- Waste Disposal 0/1
- Records Management 1/1
Product Testing 5/10
- Product Meets Requirements Before Sale 5/5
- COA Disclosure 0/5
Complaints, Adverse Event Reporting and Recall Protocol 0/13
Total 50/50
Independent or Third-Party 5/5
Laboratory Sampling 5/5
Method Validation 4/4
Quality Management Systems 5/5
Staff Training 20/20
Standard Operating Procedures 7/7
- Facility and Equipment Sanitation 1/1
- Equipment and Instrument Calibration 1/1
- Workplace Safety 1/1
- Sample Tracking 1/1
- Security 1/1
- Waste Disposal 1/1
- Records Management 1/1
Result Reporting 4/4
Score Penalties 10/100   
Gives Regulatory Preference to Adult Use 0/20
Classifies Cannabis as a Medicine of Last Resort 0/15
Administrative or Supply Problems 0/15
Requires Vertical Integration 0/10
Creates New Criminal Penalties for Patients 0/10
Limits Patients to a Single Retailer 10/10
No System for Adding Qualifying Conditions 0/10
Imposes Bans or Limits on THC 0/5
Imposes Bans or Limits on CBD 0/5
Excerpted from ASA's 2021 State of the States Report.
page icon

Becoming a Patient in Delaware

page icon

Recommending Cannabis in Delaware

page icon

History Of Medical Cannabis In Delaware

page icon

Policy Recommendations Delaware